Unverified50% confidenceFactExact time
Anti-amyloid monoclonal antibodies are a class of intravenously administered antibody drugs that can specifically bind beta-amyloid in the brain and promote its clearance; representative drugs include aducanumab and lecanemab.
1
Sources
50%
Confidence
Long-term
Relevance
10/24/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedThe mechanism of action of lecanemab and donanemab is to target and clear abnormally accumulated β-amyloid plaques in the brain, and both belong to monoclonal antibody therapies70% similarUnverifiedAntivenom is a biological product containing polyclonal antibodies against components of a specific snake or scorpion venom, rather than a small-molecule drug produced through chemical synthesis.61% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1092214API
curl https://kongchang.com/api/v1/knowledge/claims/1092214MCP
get_claim(id=1092214)